Integrated DNA Technologies (IDT), a biotechnology company based in the US, has opened a state-of-the-art synthetic biology manufacturing facility in Coralville, Iowa, close to its main headquarters, to expand its synthetic biology operations. The facility is used to manufacture a range of products, including eBlocks , gBlocks , gBlocks HiFi Gene Fragments, homology-directed repair (donor blocks, Genes, oPools Oligo Pools and other bespoke panels. It increases IDT’s production capacity and expands its gene synthesis portfolio, while diversifying its product offerings.
The development follows the opening of IDT’s in Iowa in late 2023. It signifies the company’s entry into therapeutics to support the growing global DNA synthesis market. Integrated DNA Technologies synthetic biology manufacturing facility details Integrated DNA Technologies’ synthetic biology manufacturing facility is a two-story building that spans an area of 25,000ft (2,323m ).
It is designed to double IDT’s existing synthetic biology footprint and serve as a hub for future product enhancements, including rapid gene synthesis. More than half of the facility’s space is allocated to state-of-the-art synthetic biology laboratories. The remaining areas encompass office spaces, conference rooms, amenities, and dedicated support resources and provisions for future expansions.
The laboratory is equipped with advanced cold storage capabilities, a lean manufacturing design and energy-efficient features such.